| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1191/0961203302lu262oa Heparin and osteoporosis during pregnancy: 2002 updateLupus Research Unit, The Rayne Institute, St Thomas' Hospital, London, UK; Service of Internal Medicine, Hospital de Cruces Bizkaia, Spain
Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, London SE1 7EH, UK106404.2325{at}compuserve.com
Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, London, UK Althoughsignificant bone mass loss is rare duringpregnancy,some situationsmay increasethe risk of symptomaticosteoporosis.Heparin may be necessaryfor a number of pregnantwomen with systemic lupus erythematosus and antiphospholipid syndrome. The osteopenic effect of heparin is low even during pregnancy, and recent data point to a more favourable profile of low-molecular-weight heparins as compared with unfractionated heparin. Lactation results in a significant increase of calcium demands and may be a higher risk period for women at risk for osteoporosis.
Key Words: heparin low molecular weight heparin osteoporosis pregnancy
This article has been cited by other articles:
|
||||||||||||
